Ajay Duggal, MB ChB, MRCP, Dip Pharm Med

Ajay Duggal has extensive work experience as a medical professional in various companies. Ajay has held multiple roles including Interim CMO, Managing Director, and Chief Medical Officer.

Starting in 2014, Duggal served as the Chief Medical Officer at Nerre Therapeutics Ltd until 2016. In 2018, they worked as the Interim Chief Medical Officer at OSHIHEALTH and later as the Chief Medical Officer at Abfero Inc from 2018 to 2019.

In 2020, Duggal held the position of Interim Chief Medical Officer at XENOTHERA until 2021. Ajay then joined Endpoint Health as a Interim Chief Medical Officer in 2021 and continued in the same role until 2022.

During the same period, Duggal was also the Chief Medical Officer at Topivert Limited from 2014 to 2020. Additionally, they served as the Managing Director at Adnovate Clinical from 2014 until present.

Most recently, Duggal has worked as an Interim CMO at GexVal, Race Oncology, and Endpoint Health starting from 2021. Ajay continues to hold the position of Interim CMO at Endpoint Health since December 2022.

Ajay Duggal pursued their undergraduate studies at The University of Sheffield from 1986 to 1991, where they obtained a Doctor of Medicine (MD) degree. Later on, they enrolled at the Royal College of Physicians UK in 1996 to further their education, specializing in the field of Medicine and successfully achieving the MRCP qualification.